Corticospinal tract transduction: A comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector

Gene Therapy

Volumn 19, Issue 1, 2012, Pages 49-60

  Hutson, T H ^a   Verhaagen, J ^b   Yanez Munoz R J ^c   Moon, L D F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

AAV; corticospinal tract; integration deficient lentiviral vector; spinal cord injury; transduction

Indexed keywords

ADENO ASSOCIATED VIRUS 1 VECTOR; ADENO ASSOCIATED VIRUS 2 VECTOR; ADENO ASSOCIATED VIRUS 3 VECTOR; ADENO ASSOCIATED VIRUS 4 VECTOR; ADENO ASSOCIATED VIRUS 5 VECTOR; ADENO ASSOCIATED VIRUS 6 VECTOR; ADENO ASSOCIATED VIRUS 8 VECTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 3; ADENO ASSOCIATED VIRUS 4; ADENO ASSOCIATED VIRUS 5; ADENO ASSOCIATED VIRUS 6; ADENO ASSOCIATED VIRUS 7; ADENO ASSOCIATED VIRUS 8; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CERVICAL SPINAL CORD; COMPARATIVE STUDY; CONTROLLED STUDY; GENE TARGETING; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL TRACT; RAT; SENSORIMOTOR CORTEX; SEROTYPE; SPINAL CORD INJURY; TROPISM; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM;

ANIMALS; ASTROCYTES; CELL COUNT; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LENTIVIRUS; MICROGLIA; NEURONS; PYRAMIDAL TRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEROTYPING; TRANSFECTION; VIRUS INTEGRATION;

EID: 84855453499     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.71     Document Type: Article

References (63)

1. Tracey DJ. Ascending and descending pathways in the spinal cord. The Rat Nervous System, 2nd edn. Academic Press: San Diego, 1995, pp 67-77.
2. Brosamle C, Schwab ME. Cells of origin, course, and termination patterns of the ventral, uncrossed component of the mature rat corticospinal tract. J Comp Neurol 1997; 386: 293-303. (Pubitemid 27392135)
3. Bareyre FM, Kerschensteiner M, Misgeld T, Sanes JR. Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury. Nat Med 2005; 11: 1355-1360. (Pubitemid 41752918)
4. Steward O, Zheng B, Ho C, Anderson K, Tessier-Lavigne M. The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions. J Comp Neurol 2004; 472: 463-477. (Pubitemid 38508830)
5. Lemon RN. Descending pathways in motor control. Ann Rev Neurosci 2008; 31: 195-218.
6. Whishaw IQ, Metz GA. Absence of impairments or recovery mediated by the uncrossed pyramidal tract in the rat versus enduring deficits produced by the crossed pyramidal tract. Behav Brain Res 2002; 134: 323-336. (Pubitemid 34912713)
7. Whishaw IQ, Gorny B, Sarna J. Paw and limb use in skilled and spontaneous reaching after pyramidal tract, red nucleus and combined lesions in the rat: behavioral and anatomical dissociations. Behav Brain Res 1998; 93: 167-183. (Pubitemid 28289435)
8. Starkey ML, Barritt AW, Yip PK, Davies M, Hamers FP, McMahon SB et al. Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice. Exp Neurol 2005; 195: 524-539. (Pubitemid 41297803)
9. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002; 110: 521-529. (Pubitemid 35232295)
10. Baum C, , Fehse B. Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives. Curr Opin Mol Ther 2003; 5: 458-462. (Pubitemid 37304710)
11. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006; 17: 253-263.
12. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J et al. Murine leukemia induced by retroviral gene marking. Science (New York, NY) 2002; 296: 497. (Pubitemid 34408663)
13. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (New York, NY) 2003; 302: 415-419. (Pubitemid 37296260)
14. Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005; 12: 763-771. (Pubitemid 41350158)
15. Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 2006; 12: 348-353. (Pubitemid 43355085)
16. Rahim AA, Wong AMS, Howe SJ, Buckley SMK, Acosta-Saltos AD, Elston KE et al. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther 2009; 16: 509-520.
17. McCown TJ. Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 2005; 5: 333-338. (Pubitemid 40895017)
18. Papale A, Cerovic M, Brambilla R. Viral vector approaches to modify gene expression in the brain. J Neurosci Methods 2009; 185: 1-14.
19. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007; 369: 2097-2105. (Pubitemid 46935946)
20. Lim ST, Airavaara M, Harvey BK. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 2009; 61: 14-26.
21. Vandenberghe LH, Wilson JM, Gao G. Tailoring the AAV vector capsid for gene therapy. Gene Ther 2009; 16: 311-319.
22. Burger C, Nash K, Mandel RJ. Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 2005; 16: 781-791. (Pubitemid 40982327)
23. Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 2006; 13: 528-537. (Pubitemid 43257620)
24. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801. (Pubitemid 34033377)
25. Yip PK, Wong LF, Pattinson D, Battaglia A, Grist J, Bradbury EJ et al. Lentiviral vector expressing retinoic acid receptor {beta}2 promotes recovery of function after corticospinal tract injury in the adult rat spinal cord. Hum Mol Genet 2006; 15: 3107-3118. (Pubitemid 44605493)
26. Yip PK, Wong LF, Sears TA, Yanez-Munoz RJ, McMahon SB. Cortical overexpression of neuronal calcium sensor-1 induces functional plasticity in spinal cord following unilateral pyramidal tract injury in rat. PLoS Biol 2010; 8: e1000399.
27. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP et al. KLF family members regulate intrinsic axon regeneration ability. Science (New York, NY) 2009; 326: 298-301.
28. Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 2010; 13: 1075-1081.
29. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science (New York, NY) 2008; 322: 963-966.
30. Ruitenberg MJ, Blits B, Dijkhuizen PA, te Beek ET, Bakker A, van Heerikhuize JJ et al. Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol Dis 2004; 15: 394-406. (Pubitemid 38304891)
31. Kwon BK, Liu J, Lam C, Plunet W, Oschipok LW, Hauswirth W et al. Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine 2007; 32: 1164-1173. (Pubitemid 46743016)
32. Foust KD, Flotte TR, Reier PJ, Mandel RJ. Recombinant adeno-associated virusmediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat. Hum Gene Ther 2008; 19: 71-82.
33. Hollis II ER, Jamshidi P, Low K, Blesch A, Tuszynski MH. Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc Natl Acad Sci USA 2009; 106: 7215-7220.
34. Low K, Blesch A, Herrmann J, Tuszynski MH. A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury. Gene Ther 2010; 17: 577-591.
35. Blits B, Derks S, Twisk J, Ehlert E, Prins J, Verhaagen J. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors. J Neurosci Methods 2010; 185: 257-263.
36. Nathanson JL, Yanagawa Y, Obata K, Callaway EM. Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors. Neuroscience 2009; 161: 441-450.
37. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998; 57: 1-9. (Pubitemid 28279554)
38. Cunningham J, Oiwa Y, Nagy D, Podsakoff G, Colosi P, Bankiewicz KS. Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant 2000; 9: 585-594. (Pubitemid 32002567)
39. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302-317. (Pubitemid 39117875)
40. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432. (Pubitemid 30183319)
41. Wang C, Wang CM, Clark KR, Sferra TJ. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Ther 2003; 10: 1528-1534. (Pubitemid 36987147)
42. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 2007; 18: 195-206. (Pubitemid 46626459)
43. Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther 2009; 17: 1692-1702.
44. Cearley CN, Vandenberghe LH, Parente MK, Carnish ER, Wilson JM, Wolfe JH. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol Ther 2008; 16: 1710-1718.
45. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037. (Pubitemid 23260849)
46. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (New York, NY) 1996; 272: 263-267. (Pubitemid 26119138)
47. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson¢s disease. Science (New York, NY) 2000; 290: 767-773.
48. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40. (Pubitemid 32095639)
49. Lowenstein PR, Mandel RJ, Xiong WD, Kroeger K, Castro MG. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Curr Gene Ther 2007; 7: 347-360. (Pubitemid 47595777)
50. Coil DA, Miller AD. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 2004; 78: 10920-10926. (Pubitemid 39299632)
51. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001; 75: 6884-6893. (Pubitemid 32641575)
52. Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001; 276: 20610-20616.
53. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol 2006; 80: 9093-9103. (Pubitemid 44359983)
54. Kim SM, Lee JS, Lee YH, Kim WJ, Do SI, Choo YK et al. Increased alpha2,3-sialylation and hyperglycosylation of N-glycans in embryonic rat cortical neurons during camptothecin-induced apoptosis. Mol Cells 2007; 24: 416-423.
55. Sanlioglu S, Monick MM, Luleci G, Hunninghake GW, Engelhardt JF. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 2001; 1: 137-147.
56. Thomas CE, Storm TA, Huang Z, Kay MA. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 3110-3122. (Pubitemid 38314369)
57. Hellstrom M, Ruitenberg MJ, Pollett MA, Ehlert EME, Twisk J, Verhaagen J et al. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Gene Ther 2008; 16: 521-532.
58. Blits B, Carlstedt TP, Ruitenberg MJ, de Winter F, Hermens WT, Dijkhuizen PA et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol 2004; 189: 303-316. (Pubitemid 39221824)
59. Hermens WT, ter Brake O, Dijkhuizen PA, Sonnemans MA, Grimm D, Kleinschmidt JA et al. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther 1999; 10: 1885-1891. (Pubitemid 29357694)
60. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813. (Pubitemid 34493974)
61. Paxinos G, Watson C, Pennisi M, Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 1985; 13: 139-143. (Pubitemid 15008633)
62. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Atlas. Academic Press: San Diego, 1982.
63. Neafsey EJ, Bold EL, Haas G, Hurley-Gius KM, Quirk G, Sievert CF et al. The organization of the rat motor cortex: a microstimulation mapping study. Brain Res 1986; 396: 77-96. (Pubitemid 16126208)